SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The "crow with knife" ($CAW.X) crypto is trending as its community rallies behind the meme coin, emphasizing its multi-chain presence and deflationary mechanisms. Active discussions highlight the strength of the community and the potential for significant gains. The coin's presence on multiple chains like Solana, BSC, Cronos, and ETH (Base) is a key talking point.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MLTX is trending due to positive Phase 2 trial data for its drug sonelokimab in treating hidradenitis suppurativa, leading to raised price targets and speculation about its potential as a best-in-class treatment. The community is actively discussing the implications of this data, especially compared to competitors, and the possibility of a future buyout. Some investors believe MLTX is thoroughly de-risked.

WeRide, Inc. is a holding company, which engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers, and related sensor suites. The company was founded by Tony Xu Han and Yan Li on March 13, 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRide ($WRD) is trending due to positive Q2 earnings, highlighting significant robotaxi revenue growth and expanded global operations, including a new permit in Saudi Arabia. The community is discussing the partnership with Bosch for mass production of ADAS systems and upcoming collaboration with UBER and GRAB, though some express frustration with the stock's price action despite the positive news.

BRETT the dancer, gamer, and cultural icon of BASE chain (some like to call me the PEPE of BASE).

Brett

BRETT.X is trending as the community debates its potential amidst discussions about a potential breakout and comparisons to other cryptocurrencies like JTRAMBO and TOSHI.X.  Some traders are buying the dips and expressing long-term bullish sentiment, while others are skeptical, citing concerns about market cap and exchange listings. Conversations also mention potential catalysts and technical analysis pointing to possible upside.

Meet Pandu — your AI friend who’s always by your side. Talk with him in real time through text or voice, share your thoughts, ask questions, or just enjoy a casual conversation. Whether you’re looking for advice, company, or simply someone to listen, Pandu is here as a true companion you can connect with anytime.  Pandu unites real-time conversation, creative generation, and future-ready AI systems — all powered by next-gen technology.

Pandu Pandas

Pandu Pandas ($PANDU.X) is trending as the community discusses its potential, recent listing on MEXC, and comparisons to other tokens like $PENGU.X. Some users are pointing to its NFT ranking and on-chain fundamentals, while others are debating wallets and entry points.

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Insmed Inc

Insmed ($INSM) is trending amid community excitement surrounding positive data and potential FDA approval of Brensocatib for bronchiectasis, with some analysts projecting blockbuster status and a buyout. Discussions also involve the potential of TPIP and a possible expansion into new indications. Community members are closely watching upcoming presentations and potential impacts on competitors like $UTHR.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending, and the community is actively engaging with the classic "What's UpDog?" joke, driving social volume. Some users are pointing out the project has been live on Solana for over a year and has a locked and burned LP. Others suggest the recent increase in social volume is due to only one or two accounts.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI.X is trending as the community emphasizes its importance as the tokenized representation of Satoshi Nakamoto, the pseudonymous creator of Bitcoin. Community members are actively discussing its potential as a cultural icon within the crypto industry, highlighting the 'We are all Satoshi' movement and its never-fading narrative.

Blockchain-on-Blockchain (BOB) is a new blockchain built on top of another blockchain called ICP. It's like a special layer on an existing system. BOB creates a secure digital record book that uses ICP's network for safety. BOB uses a system called 'proof-of-on-chain-work': You deploy your own smart contract (canister) at bob.fun. This program solves math problems (hashes). Main computers (mother nodes) give out these problems. Miners solve the problems and tell the mother node. If correct, the mother node adds a new block to the blockchain. The winning miner gets BOB tokens as a reward.

$BOB.X is trending as community members discuss its capped supply and upcoming halving, drawing comparisons to $BTC.X and its potential within web3. Some users are highlighting its availability on multiple chains and mining via $ICP.X, while others are comparing it to other meme coins.

ProShares Trust - ProShares VIX Short-Term Futures ETF

ProShares VIX Short-Term Futures ETF

VIXY is trending as traders monitor rising volatility, influenced by factors like rising long-term rates, potential bubble bursts, and geopolitical tensions (war on deck). Community members are actively discussing downside protection strategies and hedging portfolios with volatility-linked instruments. Some traders believe yearly charts point to significant moves ahead, while others note VIXY's potential disconnect from the VIX.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Cabot (CBT) Up 0.9% Since Last Earnings Report?

Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Huntsman's Earnings and Revenues Lag Estimates in Q2, Down Y/Y

HUN posts wider-than-expected Q2 loss and lower revenues, hit by weak construction and industrial demand and reduced prices.

Huntsman (HUN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Huntsman (HUN) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Huntsman (HUN) Reports Q2 Loss, Misses Revenue Estimates

Huntsman (HUN) delivered earnings and revenue surprises of -33.33% and -1.26%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Stepan Co. (SCL) Q2 Earnings and Revenues Lag Estimates

Stepan Co. (SCL) delivered earnings and revenue surprises of -43.48% and -0.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Avient (AVNT) Reports Next Week: Wall Street Expects Earnings Growth

Avient (AVNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Huntsman (HUN) to Report a Decline in Earnings: What to Look Out for

Huntsman (HUN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BofA downgrades U.S. chemical sector amid slowdown

Investing.com -- Bank of America downgraded its view on the U.S. chemicals sector after a sharp selloff and worsening macro conditions, cutting price objectives by 15% on average.

Huntsman Announces First Quarter 2025 Common Dividend and 2025 Annual Meeting of Stockholders

Huntsman Announces First Quarter 2025 Common Dividend and 2025 Annual Meeting of Stockholders Huntsman Announces First Quarter 2025 Common Dividend and 2025 Annual Meeting of Stockholders PR Newswire...

Huntsman Announces Fourth Quarter 2024 Earnings

Huntsman Announces Fourth Quarter 2024 Earnings Huntsman Announces Fourth Quarter 2024 Earnings PR Newswire THE WOODLANDS, Texas, Feb. 17, 2025 Fourth Quarter Highlights Fourth quarter 2024 net loss...

Huntsman Corp. engages in the manufacturing of differentiated organic chemical products. It operates through the following segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment manufactures and markets polyurethane chemicals, including MDI products, PO, polyols, PG, TPU, aniline, and MTBE. The Performance Products segment produces and sells amines, surfactants, LAB, and maleic anhydride to a variety of consumer and industrial end markets. The Advanced Materials segment provides basic liquid and solid epoxy resins, specialty resin compounds, cross linking, matting and curing agents, epoxy, acrylic, and polyurethane based polymer products. The company was founded by Jon Meade Huntsman Sr. in 1970 and is headquartered in The Woodlands, TX.

Huntsman Corp

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

Current Price	$8.98
Prev Close	$8.89
Open	$8.98
Dividend Yield	5.55%
50-Day Moving Average	$10.38
Beta	1.11
Avg. Volume	4.78M
PE Ratio	-4.99

52-Week High	$24.45
52-Week Low	$8.82
Market Capitalization	$1.56B
EPS (Annual)	-$0.9413
Price to Book	0.55
Revenue Per Employee	$958,095.24
Enterprise Value/EBITDA	N/A

HUN
Huntsman Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HUN News

HUN Huntsman Corp